Blood advances (2022). doi:10.1182/bloodadvances.2021006889 info:cnr-pdr/source/autori:Maffioli, Margherita and Mora, Barbara and Ball, Somedeb and Iurlo, Alessandra and Elli, Elena Maria and Finazzi, Maria Chiara and Polverelli, Nicola and Rumi, Elisa and Caramella, Marianna and Carraro, Maria Cristina and D'Adda, Mariella and Molteni, Alfredo and Sissa, Cinzia and Lunghi, Francesca and Vismara, Alessandro and Ubezio, Marta and Guidetti, Anna and Caberlon, Sabrina and Anghilieri, Michela and Komrokji, Rami S. and Cattaneo, Daniele and Della Porta, Matteo Giovanni and Giorgino, Toni and Bert?, Lorenza and Brociner, Marco and Kuykendall, Andrew T and Passamonti, Francesco/titolo:A Prognostic Model to Predict Survival After 6 Months of Ruxolitinib in Patients with Myelofibrosis/doi:10.1182%2Fbloodadvances.2021006889/rivista:Blood advances/anno:2022/pagina_da:/pagina_a:/intervallo_pagine:/volume
Cancer Medicine Cancer Medicine 8 (2019): 4089–4092. doi:10.1002/cam4.2107 info:cnr-pdr/source/autori:Mora, Barbara and Rumi, Elisa and Guglielmelli, Paola and Barraco, Daniela and Maffioli, Margherita and Rambaldi, Alessandro and Caramella, Marianna and Komrokji, Rami and Gotlib, Jason and Kiladjian, Jean Jacques and Cervantes, Francisco and Devos, Timothy and Palandri, Francesca and De Stefano, Valerio and Ruggeri, Marco and Silver, Richard T. and Benevolo, Giulia and Albano, Francesco and Cavalloni, Chiara and Pietra, Daniela and Barbui, Tiziano and Rotunno, Giada and Cazzola, Mario and Vannucchi, Alessandro Maria and Giorgino, Toni and Passamonti, Francesco/titolo:Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients/doi:10.1002%2Fcam4.2107/rivista:Cancer Medicine/anno:2019/pagina_da:4089/pagina_a:4092/intervallo_pagine:4089–4092/volume:8 Cancer Medicine, Vol 8, Iss 9, Pp 4089-4092 (2019)